Aging science, cellular health, peptides, stem cells, and longevity protocols.
Aging Biomarkers
A 2024 IVF study found rapamycin improved ovarian reserve metrics in aging women, suggesting the mTOR inhibitor may reverse cellular sene...
Aging Biomarkers
For decades, resveratrol in red wine was championed as a longevity miracle. Recent large-scale studies and meta-analyses reveal the reali...
Peptides
VD11 peptide has emerged in biohacking circles as a potential senolytic agent, but human research remains sparse. This analysis separates...
Peptides
New regulatory frameworks governing peptide-based hormone replacement therapies are reshaping access to synthetic peptides for anti-aging...
Peptides
New regulatory guidelines are reshaping peptide-based hormone replacement therapy availability. We break down what's changing, the scienc...
Peptides
While researchers pursue expensive senolytics and NAD+ boosters, oxytocin peptide's capacity to reduce senescent cell burden and restore ...
Aging Biomarkers
Scientists have identified senescent cells—zombie-like cells that refuse to die—as a primary driver of aging. Recent studies show tha...
Peptides
Weekly peptide administration in HRT protocols demonstrates superior hormonal stability and reduced adverse effects compared to daily dos...
Peptides
Recent 2026 data reveals that combining specific peptides with hormone replacement therapy produces measurably superior tissue regenerati...
Skin & Beauty
A systematic 12-week skin care protocol combining prescription retinoids with clinically-studied peptides produced quantifiable reduction...
Skin & Beauty
After abandoning traditional retinoid protocols due to chronic irritation, I implemented a micro-dosing strategy combined with peptide se...
Peptides
The rapid proliferation of peptide discussions in biohacking communities has outpaced peer-reviewed validation. This analysis examines th...